Cargando…

Balancing Benefits and Risks of Long-Term Antiplatelet Therapy in Noncardioembolic Transient Ischemic Attack or Stroke

Lifelong treatment with antiplatelet drugs is recommended following a transient ischemic attack or ischemic stroke. Bleeding complications may offset the benefit of antiplatelet drugs in patients at increased risk of bleeding and low risk of recurrent ischemic events. We aimed to investigate the net...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hilkens, Nina A., Algra, Ale, Diener, Hans Christoph, Bath, Philip M., Csiba, László, Hacke, Werner, Kappelle, L. Jaap, Koudstaal, Peter J., Leys, Didier, Mas, Jean-Louis, Sacco, Ralph L., Greving, Jacoba P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Original Contributions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478107/ https://www.ncbi.nlm.nih.gov/pubmed/34304604 http://dx.doi.org/10.1161/STROKEAHA.120.031755

Ejemplares similares

Antiplatelet Therapy After Noncardioembolic Stroke: An Individual Patient Data Network Meta-Analysis
por: Greving, Jacoba P., et al.
Publicado: (2019)

Early time course of major bleeding on antiplatelet therapy after TIA or ischemic stroke
por: Hilkens, Nina A., et al.
Publicado: (2018)

Refining prediction of major bleeding on antiplatelet treatment after transient ischaemic attack or ischaemic stroke
por: Hilkens, Nina A, et al.
Publicado: (2020)

External Validation of Risk Scores for Major Bleeding in a Population-Based Cohort of Transient Ischemic Attack and Ischemic Stroke Patients
por: Hilkens, Nina A., et al.
Publicado: (2018)

Nonfocal transient neurological attacks in patients with carotid artery occlusion
por: Oudeman, Eline A, et al.
Publicado: (2018)

Dual Antiplatelet Therapy after Noncardioembolic Ischemic Stroke or Transient Ischemic Attack: Pros and Cons
por: Hong, Keun-Sik
Publicado: (2014)

Prediction models for clinical outcome after a carotid revascularisation procedure: A systematic review
por: Volkers, Eline J, et al.
Publicado: (2017)

Nonfocal transient neurological attacks are related to cognitive impairment in patients with heart failure
por: Oudeman, Eline A., et al.
Publicado: (2019)

Prediction Models for Clinical Outcome After a Carotid Revascularization Procedure: An External Validation Study
por: Volkers, Eline J., et al.
Publicado: (2018)

Transient monocular blindness and the risk of vascular complications according to subtype: a prospective cohort study
por: Volkers, Eline J., et al.
Publicado: (2016)

Diagnostic Accuracy of the Explicit Diagnostic Criteria for Transient Ischemic Attack: A Validation Study
por: Dolmans, L. Servaas, et al.
Publicado: (2019)

Safety of Carotid Revascularization in Patients With a History of Coronary Heart Disease
por: Volkers, Eline J., et al.
Publicado: (2019)

Bilateral carotid artery occlusion with transient or moderately disabling ischaemic stroke: clinical features and long-term outcome
por: Persoon, Suzanne, et al.
Publicado: (2009)

Antiplatelet Treatment After Transient Ischemic Attack and Ischemic Stroke in Patients With Cerebral Microbleeds in 2 Large Cohorts and an Updated Systematic Review
por: Lau, Kui Kai, et al.
Publicado: (2018)

Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials
por: Rothwell, Peter M, et al.
Publicado: (2016)

Stopping “transient ischemic attacks” by antiplatelet withdrawal
por: Palaiodimou, Lina, et al.
Publicado: (2021)

Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack
por: Wang, Yongjun, et al.
Publicado: (2019)

The role of CYP2C19 genotyping to guide antiplatelet therapy following ischemic stroke or transient ischemic attack
por: McDermott, John H, et al.
Publicado: (2022)

Delay in patients suspected of transient ischaemic attack: a cross-sectional study
por: Dolmans, L Servaas, et al.
Publicado: (2019)

Microbleeds as a predictor of intracerebral haemorrhage and ischaemic stroke after a TIA or minor ischaemic stroke: a cohort study
por: Kwa, Vincent I H, et al.
Publicado: (2013)

Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin
por: Amarenco, Pierre, et al.
Publicado: (2020)

Prognostic Significance of Blood Pressure Variability on Beat-to-Beat Monitoring After Transient Ischemic Attack and Stroke
por: Webb, Alastair J.S., et al.
Publicado: (2018)

Clinical Correlates, Ethnic Differences, and Prognostic Implications of Perivascular Spaces in Transient Ischemic Attack and Ischemic Stroke
por: Lau, Kui-Kai, et al.
Publicado: (2017)

Etiological Subtypes of Transient Ischemic Attack and Ischemic Stroke in Chronic Kidney Disease: Population-Based Study
por: Kelly, Dearbhla M., et al.
Publicado: (2020)

No Additional Prognostic Value of Genetic Information in the Prediction of Vascular Events after Cerebral Ischemia of Arterial Origin: The PROMISe Study
por: Achterberg, Sefanja, et al.
Publicado: (2015)

Costs and outcomes of noncardioembolic ischemic stroke in a managed care population
por: Engel-Nitz, Nicole M, et al.
Publicado: (2010)

Long-Term Prognosis of Patients With Transient Ischemic Attack or Stroke and Symptomatic Vascular Disease in Multiple Arterial Beds
por: Heldner, Mirjam R., et al.
Publicado: (2018)

Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial
por: van Nieuwenhuizen, Koen M., et al.
Publicado: (2015)

Confounding of Cerebral Blood Flow Velocity by Blood Pressure During Breath Holding or Hyperventilation in Transient Ischemic Attack or Stroke
por: Webb, Alastair J.S., et al.
Publicado: (2020)

Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack
por: Johnston, S. Claiborne, et al.
Publicado: (2021)

PAIS: paracetamol (acetaminophen) in stroke; protocol for a randomized, double blind clinical trial. [ISCRTN 74418480]
por: van Breda, Eric J, et al.
Publicado: (2005)

Correction: PAIS: paracetamol (acetaminophen) in stroke; protocol for a randomized, double blind clinical trial. [ISCRTN74418480]
por: den Hertog, Heleen M, et al.
Publicado: (2008)

Risk Factors for Lobar and Non-Lobar Intracerebral Hemorrhage in Patients with Vascular Disease
por: Kremer, Philip H. C., et al.
Publicado: (2015)

Sodium Valproate, a Histone Deacetylase Inhibitor, Is Associated With Reduced Stroke Risk After Previous Ischemic Stroke or Transient Ischemic Attack
por: Brookes, Rebecca L., et al.
Publicado: (2018)

Age-Specific Associations of Renal Impairment With Magnetic Resonance Imaging Markers of Cerebral Small Vessel Disease in Transient Ischemic Attack and Stroke
por: Liu, Bian, et al.
Publicado: (2018)

Essen Risk Score in Prediction of Myocardial Infarction After Transient Ischemic Attack or Ischemic Stroke Without Prior Coronary Artery Disease
por: Boulanger, Marion, et al.
Publicado: (2019)

An early rise in body temperature is related to unfavorable outcome after stroke: data from the PAIS study
por: den Hertog, Heleen M., et al.
Publicado: (2010)

Long-Term Impact of Urgent Secondary Prevention After Transient Ischemic Attack and Minor Stroke: Ten-Year Follow-Up of the EXPRESS Study
por: Luengo-Fernandez, Ramon, et al.
Publicado: (2021)

Serum biomarkers in patients suspected of transient ischaemic attack in primary care: a diagnostic accuracy study
por: Dolmans, Louis Servaas, et al.
Publicado: (2019)

Dual antiplatelet therapy reduced stroke risk in transient ischemic attack with positive diffusion weighted imaging
por: Pei, Lu-lu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vk5jsis94aau02e6rb5unrqjbt